
|Articles|January 1, 2007
Plop, Plop, Fizz, Fizz-and You Can Be a Workout Whiz
When patients cite muscle pain anddiscomfort as an excuse for not exercisingregularly, suggest they try anapproach that athletes use.
Advertisement
When patients cite muscle pain and discomfort as an excuse for not exercising regularly, suggest they try an approach that athletes use. Taking Alka-Seltzer after working out can make muscle-building less painful. Alka-Seltzer contains sodium bicarbonate and aspirin; the sodium bicarbonate alkalinizes the lactic acid produced by the muscles during exertion, and the aspirin helps ease the pain while the kidneys flush the toxins. Do not recommend this use of Alka-Seltzer to patients who are allergic to any of its ingredients, or to those with kidney problems.
- Debra M. Monde, DO
Abilene, Tex
Advertisement
Related to this article

AHA 2026: Yoga-based cardiac rehabilitation improved quality of life and walking distance in patients with HFrEF but did not significantly reduce death, hospitalization, or stroke.

The ACS 2026 prostate cancer screening guidelines recommend risk-based PSA testing beginning at age 45 or 50, with updated follow-up thresholds.

Retatrutide trials report less knee osteoarthritis pain; ixekizumab plus tirzepatide shows exploratory ACR50 benefits in psoriatic arthritis.

Asundexian reduced relative ischemic stroke risk by 26% alongside antiplatelet therapy, with bleeding concerns in older adults.

Survodutide demonstrated cardiovascular safety vs placebo in the phase 3 SYNCHRONIZE-CVOT trial, with improvements in weight and cardiometabolic risk factors.

Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.

The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Asundexian for Stroke Prevention After Ischemic Stroke or TIA
2
Retatrutide Phase 3 Trials Report Reduced Knee Osteoarthritis Pain
3
Contraindicated Hormone Therapy Prescribing Climbs in Primary Care
4
New Study Shows Menopause Undercoded in Primary Care, With Gaps by Race and Insurance
5

